Pulmonx Corporation (LUNG) — Analyst outlook / Analyst consensus target is. Based on 9 analyst ratings, the consensus is bullish — 4 Buy, 4 Hold, 1 Sell.
The consensus price target is $4.00, representing an upside of 166.7% from the current price $1.50.
Analysts estimate Earnings Per Share (EPS) of $-1.56 and revenue of $0.08B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.44 vs est $-1.56 (beat +7.6%). 2025: actual $-1.33 vs est $-1.45 (beat +8.1%). Analyst accuracy: 92%.
LUNG Stock — 12-Month Price Forecast
$4.00
▲ +166.67% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Pulmonx Corporation, the price target is $4.00.
The average price target represents a +166.67% change from the last price of $1.50.
LUNG Analyst Ratings
Buy
Based on 9 analysts giving stock ratings to Pulmonx Corporation in the past 3 months
EPS Estimates — LUNG
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.44
vs Est –$1.56
▲ 8.2% off
2025
Actual –$1.33
vs Est –$1.45
▲ 8.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — LUNG
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.084B
vs Est $0.082B
▲ 1.8% off
2025
Actual $0.090B
vs Est $0.090B
▲ 1.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
